journal article·2021-11-17Open access

Uptake Dynamics of Cubosome Nanocarriers at Bacterial Surfaces and the Routes for Cargo Internalization

Brendan P. Dyett, Haitao Yu, Sampa Sarkar, Jamie B. Strachan, Calum J. Drummond, Charlotte E. Conn

ACS Applied Materials & Interfaces· Volume 13· Issue 45

Abstract

Antibiotic-resistant bacteria pose a significant threat to humanity. Gram-negative strains have demonstrated resistance to last resort antibiotics, partially due to their outer membrane, which hinders transport of antimicrobials into the bacterium. Nanocarrier (NC)-mediated drug delivery is one proposed strategy for combating this emerging issue. Here, the uptake of self-assembled lipid nanocarriers of cubic symmetry (cubosomes) into bacteria revealed fundamental differences in the uptake mechanism between Gram-positive and Gram-negative bacteria. For Gram-positive bacteria, the NCs adhere to the outer peptidoglycan layers and slowly internalize to the bacterium. For Gram-negative bacteria, the NCs interact in two stages, fusion with the outer lipid membrane and then diffusion through the inner wall. The self-assembled nature of the cubosomes imparts a unique ability to transfer payloads via membrane fusion. Remarkably, the fusion uptake mechanism allowed rapid NC internalization by the Gram-negative bacteria, overcoming the outer membrane responsible for their heightened resilience. Here this is demonstrated by the marked reduction in the minimal inhibition concentration required for antibiotics against a pathogenic strain of Gram-negative bacteria, Escherichia coli. These results provide mechanistic insight for the development of lipid NCs as a new tool to combat bacteria.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bacteriophages and microbial interactions · Antibiotic Resistance in Bacteria · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Science, STEM College, RMIT University, Melbourne, Victoria 3000, Australia

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Department of Chemical Engineering, University of Melbourne, Melbourne, Victoria 3010, Australia

Funding

RMIT University

References (61)

Show source-provided references
1. 2014
2. 10.1016/S1473-3099(13)70318-910.1016/S1473-3099(13)70318-9 ↗
3. 10.1038/nrd397510.1038/nrd3975 ↗
4. 10.1038/nature1704210.1038/nature17042 ↗
5. 2017
6. 10.1038/s41586-019-1665-610.1038/s41586-019-1665-6 ↗
7. 10.1038/s41586-019-1791-110.1038/s41586-019-1791-1 ↗
8. 10.1016/S1473-3099(15)00463-610.1016/S1473-3099(15)00463-6 ↗
9. 10.1016/j.bmc.2016.06.04410.1016/j.bmc.2016.06.044 ↗
10. 10.1016/j.addr.2017.12.01010.1016/j.addr.2017.12.010 ↗
11. 10.1038/nrmicro.2017.9910.1038/nrmicro.2017.99 ↗
12. 10.1016/j.jconrel.2016.01.00810.1016/j.jconrel.2016.01.008 ↗
13. 10.1038/nbt.261410.1038/nbt.2614 ↗
14. 10.1021/acsnano.5b0390210.1021/acsnano.5b03902 ↗
15. 10.2147/IJN.S2659210.2147/IJN.S26592 ↗
16. 10.1021/acs.langmuir.6b0442310.1021/acs.langmuir.6b04423 ↗
17. 10.1021/acsabm.9b0018710.1021/acsabm.9b00187 ↗
18. 10.1016/j.jcis.2020.05.00210.1016/j.jcis.2020.05.002 ↗
19. 10.1021/la802768q10.1021/la802768q ↗
20. 10.1016/j.cis.2014.11.00310.1016/j.cis.2014.11.003 ↗
21. 10.1021/acsnano.8b0796110.1021/acsnano.8b07961 ↗
22. 10.1002/anie.20180406710.1002/anie.201804067 ↗
23. 10.1073/pnas.93.25.1453210.1073/pnas.93.25.14532 ↗
24. 10.1039/c3sm27743g10.1039/c3sm27743g ↗
25. 10.1021/acs.molpharmaceut.8b0089010.1021/acs.molpharmaceut.8b00890 ↗
26. 10.1016/j.colsurfb.2017.01.00410.1016/j.colsurfb.2017.01.004 ↗
27. 10.1016/j.ijpharm.2017.04.08210.1016/j.ijpharm.2017.04.082 ↗
28. 10.1016/j.ejpb.2018.11.00910.1016/j.ejpb.2018.11.009 ↗
29. 10.1016/j.jcis.2020.11.12410.1016/j.jcis.2020.11.124 ↗
30. 10.1002/anie.20120592310.1002/anie.201205923 ↗
31. 10.1016/j.jiec.2011.11.03110.1016/j.jiec.2011.11.031 ↗
32. 10.1021/acsami.9b2178310.1021/acsami.9b21783 ↗
33. 10.1016/j.jcis.2021.02.02710.1016/j.jcis.2021.02.027 ↗
34. 10.1080/1061186029000752210.1080/10611860290007522 ↗
35. 10.2147/IJN.S4261710.2147/IJN.S42617 ↗
36. 10.1021/bi002030k10.1021/bi002030k ↗
37. 10.1016/S0005-2736(99)00217-510.1016/S0005-2736(99)00217-5 ↗
38. 10.1093/jac/41.1.3510.1093/jac/41.1.35 ↗
39. 10.1016/j.ijantimicag.2005.10.02110.1016/j.ijantimicag.2005.10.021 ↗
40. 10.1016/j.ijpharm.2009.11.03310.1016/j.ijpharm.2009.11.033 ↗
41. 10.1128/AAC.01542-0810.1128/AAC.01542-08 ↗
42. 10.1016/j.biomaterials.2010.08.07610.1016/j.biomaterials.2010.08.076 ↗
43. 10.1016/j.jcis.2018.02.04810.1016/j.jcis.2018.02.048 ↗
44. 10.1021/acsbiomaterials.0c0008510.1021/acsbiomaterials.0c00085 ↗
45. 10.1038/s41467-019-12508-810.1038/s41467-019-12508-8 ↗
46. 10.1021/bi301573w10.1021/bi301573w ↗
47. 10.1039/D0RA06120D10.1039/D0RA06120D ↗
48. 10.1021/acsami.9b0182610.1021/acsami.9b01826 ↗
49. 10.1098/rspb.1957.004310.1098/rspb.1957.0043 ↗
50. 10.1016/S0022-5320(67)80084-410.1016/S0022-5320(67)80084-4 ↗
51. 10.1021/ja026085g10.1021/ja026085g ↗
52. 10.1016/j.jconrel.2019.12.03710.1016/j.jconrel.2019.12.037 ↗
53. 10.1002/advs.20180122310.1002/advs.201801223 ↗
54. 10.1016/S1473-3099(01)00091-310.1016/S1473-3099(01)00091-3 ↗
55. 10.1111/jfs.1258110.1111/jfs.12581 ↗
56. 10.1038/srep0921610.1038/srep09216 ↗
57. 10.1016/S0140-6736(98)01267-710.1016/S0140-6736(98)01267-7 ↗
58. 10.1016/j.ijpharm.2015.08.07210.1016/j.ijpharm.2015.08.072 ↗
59. 10.1101/cshperspect.a02543710.1101/cshperspect.a025437 ↗
60. 10.1016/j.ijantimicag.2010.10.00910.1016/j.ijantimicag.2010.10.009 ↗
61. Allan D. · 2016